SPOTLIGHT: Who's the best CEO of them all?

Who'll brave the pitfalls of generic competition and restless shareholders and pipeline pressure to be the last Big Pharma/Big Biotech CEO standing? That's what the WSJ Health Blog is asking with a new tourney bracket pitting the likes of Pfizer's Jeff Kindler (photo) and Genentech's Arthur Levinson (photo) against one another. Fill in the blanks to reach your own conclusions. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.